Methods for identifying a candidate for treatment of obesity

Details Methods for identifying a candidate for treatment of obesity Methods for identifying a candidate for treatment of obesity

2007-10-09

2007-10-09

Andres, Janet L. (Department: 1649)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091100, C435S091200, C514S002600

Reexamination Certificate

active

11177860

ABSTRACT:
Methods of identifying human subjects for treatment of obesity or an obesity-related condition with ciliary neurotrophic factor (CNTF) or a CNTF-related molecule, such as Axokine®, based on the presence of human leukocyte antigen (HLA) DRβ1 allele 1501 or the absence of HLA DRβ1 allele 0701.

REFERENCES:
patent: 6472178 (2002-10-01), Fandl et al.
patent: 6565869 (2003-05-01), Ciliberto et al.
patent: 2004/0082000 (2004-04-01), Stanton, Jr.
patent: WO 01/89550 (2001-11-01), None
Klitz et al. Tissue Antigens 2003. 62:296-307.
Ghodke et al. Eur. J. Epidemiol. 2005. 20: 475-488.
Vergara et al. Brain Res. Rev. 2004. 47:161-173.
Heward et al. Eur. J. Immunogenet. 2002. 29: 47-52.
Motala et al. Clin. Diag. Lab. Immunol. 2005. 12:213-217.
Voorter et al. Human Immunol. 2005. 66: 826-835.
Perez-Luque et al. Hum. Immunol. 2003. 64: 110-118.
Gibert, M., et al., (2003) Human Immunology 64(10):930-935.
Price, P., et al., (2001) Immunology and Cell Biology 79(6):602-606.

Affiliated with

Also associated with

Rating

Methods for identifying a candidate for treatment of obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for identifying a candidate for treatment of obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying a candidate for treatment of obesity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3895759